Advanced epithelial ovarian cancer: 1993 consensus statementsDarlene Allen, Elisabeth G.E. de Vries, K. Bertelsen et al.|Annals of Oncology|1993Cited by 185
Phase I and pharmacokinetic study of HGS-ETR2, a human monoclonal antibody to TRAIL R2, in patients with advanced solid malignanciesSimon Pacey, Johann S. de Bono, Ruth Plummer et al.|Journal of Clinical Oncology|2005Cited by 22